Gut Microbiota and Atherosclerosis-Reference-Cited by-同舟云学术

Gut Microbiota and Atherosclerosis

Published:2017-08-25 Issue:10 Volume:19 Page:
ISSN:1523-3804
Container-title:Current Atherosclerosis Reports
language:en
Short-container-title:Curr Atheroscler Rep

Author:

Li Daniel Y.,Tang W. H. Wilson

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine

Link

http://link.springer.com/article/10.1007/s11883-017-0675-9/fulltext.html

Reference108 articles.

1. Gilbert A, Lion G. Arterites infectieuses experimentales. Comptes Rendus Hebdomadaires des Seances et Memoires de la Societe de Biologie. 1889;41:583–4.

2. Zhang T, Kurita-Ochiai T, Hashizume T, Du Y, Oguchi S, Yamamoto M. Aggregatibacter actinomycetemcomitans accelerates atherosclerosis with an increase in atherogenic factors in spontaneously hyperlipidemic mice. FEMS Immunol Med Microbiol. 2010;59(2):143–51.

3. Hayashi C, Viereck J, Hua N, et al. Porphyromonas gingivalis accelerates inflammatory atherosclerosis in the innominate artery of ApoE deficient mice. Atherosclerosis. 2011;215(1):52–9.

4. Hayashi C, Madrigal AG, Liu X, et al. Pathogen-mediated inflammatory atherosclerosis is mediated in part via toll-like receptor 2-induced inflammatory responses. J Innate Immun. 2010;2(4):334–43.

5. Mattila KJ, Nieminen MS, Valtonen VV, et al. Association between dental health and acute myocardial infarction. BMJ. 1989;298(6676):779–81.

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The association between trimethylamine N-oxide levels and coronary microvascular dysfunction and prognosis in patients with ST-elevation myocardial infarction;Atherosclerosis;2024-09

2. Pharmacological characterization of the antidiabetic drug metformin in atherosclerosis inhibition: A comprehensive insight;Immunity, Inflammation and Disease;2024-08

3. Modulation of gut microbiome in the treatment of neurodegenerative diseases: A systematic review;Clinical Nutrition;2024-07

4. The effect of microbiome therapy on COVID-19-induced gut dysbiosis: A narrative and systematic review;Life Sciences;2024-04

5. Systems Biology in Understanding the Human Gut Microbiome and Related Diseases Highlighting Metabolic Modeling and Analysis;Systems Biology Approaches: Prevention, Diagnosis, and Understanding Mechanisms of Complex Diseases;2024